Literature DB >> 12686872

Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats.

Trinity J Bivalacqua1, Mustafa F Usta, Hunter C Champion, Dave Adams, Dennis B Namara, Asim B Abdel-Mageed, Philip J Kadowitz, Wayne J G Hellstrom.   

Abstract

PURPOSE: We determined whether adenoviral gene transfer of endothelial nitric oxide synthase (eNOS) to the penis of streptozotocin induced diabetic rats could improve the impaired erectile response.
MATERIALS AND METHODS: Two experimental groups of animals were transfected with adenoviruses, including streptozotocin (Sigma Chemical Company, St. Louis, Missouri) diabetic rats with AdCMVbetagal and streptozotocin diabetic rats with AdCMVeNOS. At 1 to 2 days after transfection these study animals underwent cavernous nerve stimulation to assess erectile function and their responses were compared with those of age matched control rats. In control and transfected streptozotocin diabetic rats eNOS and neuronal NOS (nNOS) were examined by Western blot analysis. Constitutive and inducible NOS activities were evaluated in the presence and absence of calcium by L-arginine to L-citrulline conversion and nitrate plus nitrite levels were measured. In control and streptozotocin diabetic penes beta-galactosidase activity and localization were determined.
RESULTS: After transfection with AdCMVbetagal beta-galactosidase was localized to the endothelium and smooth muscle cells of the streptozotocin diabetic rat penis. Streptozotocin diabetic rats had a significant decrease in erectile function, as determined by peak and total intracavernous pressure (area under the curve) after cavernous nerve stimulation compared with control rats. Streptozotocin diabetic rats transfected with AdCMVeNOS had peak intracavernous pressure and area under the curve similar to those in control animals. This change in erectile function was a result of eNOS over expression with an increase in eNOS protein expression and constitutive NOS activity as well as an increase in nitric oxide biosynthesis, as reflected by an increase in cavernous nitrate plus nitrite formation. There was no change in nNOS protein expression or calcium independent conversion of NOS (inducible NOS activity).
CONCLUSIONS: Adenoviral gene transfer of eNOS significantly increased peak and total intracavernous pressure to cavernous nerve stimulation in streptozotocin diabetic rats to a value similar to the response observed in control rats. Our results suggest that eNOS contributes significantly to the physiology of penile erection. These data demonstrate that in vivo adenoviral gene transfer of eNOS can physiologically improve erectile function in the streptozotocin diabetic rat.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12686872     DOI: 10.1097/01.ju.0000051881.14239.4a

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  24 in total

Review 1.  Therapy of erectile dysfunction: potential future treatments.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

2.  Transplantation of nonhematopoietic adult bone marrow stem/progenitor cells isolated by p75 nerve growth factor receptor into the penis rescues erectile function in a rat model of cavernous nerve injury.

Authors:  Muammer Kendirci; Landon Trost; Benjamin Bakondi; Mandolin J Whitney; Wayne J G Hellstrom; Jeffrey L Spees
Journal:  J Urol       Date:  2010-08-21       Impact factor: 7.450

Review 3.  Canonical transient receptor potential channels in diabetes.

Authors:  Sarabeth Graham; Joseph P Yuan; Rong Ma
Journal:  Exp Biol Med (Maywood)       Date:  2012-01-26

4.  Effect of low-energy shockwave therapy on angiogenic factors in the penile tissue of diabetic rats.

Authors:  Mazhar Ortaç; Canan Küçükergin; Emre Salabaş; Şule Seçkin; Ateş Kadıoğlu
Journal:  Turk J Urol       Date:  2017-05-03

5.  Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction.

Authors:  Biljana Musicki; Melissa F Kramer; Robyn E Becker; Arthur L Burnett
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-05       Impact factor: 11.205

Review 6.  Emerging and novel therapeutic approaches in the treatment of male erectile dysfunction.

Authors:  Eric Chung; Gerald B Brock
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

Review 7.  Emerging tools for erectile dysfunction: a role for regenerative medicine.

Authors:  Lukman Hakim; Frank Van der Aa; Trinity J Bivalacqua; Petter Hedlund; Maarten Albersen
Journal:  Nat Rev Urol       Date:  2012-07-24       Impact factor: 14.432

8.  Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism.

Authors:  Hunter C Champion; Trinity J Bivalacqua; Eiki Takimoto; David A Kass; Arthur L Burnett
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-24       Impact factor: 11.205

9.  [Therapy of erectile dysfunction in 2005].

Authors:  H Porst
Journal:  Urologe A       Date:  2003-10       Impact factor: 0.639

10.  Alternatively spliced neuronal nitric oxide synthase mediates penile erection.

Authors:  K Joseph Hurt; Sena F Sezen; Hunter C Champion; Julie K Crone; Michael A Palese; Paul L Huang; Akira Sawa; Xiaojiang Luo; Biljana Musicki; Solomon H Snyder; Arthur L Burnett
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.